CMMB Stock Analysis: Buy, Sell, or Hold?
CMMB - Chemomab Therapeutics Ltd. American Depositary Share
$2.27
0.57 (33.53%)
▲
5d:
+45.51%
30d:
+30.46%
90d:
+42.77%
WAIT
LOW Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When CMMB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: CMMB is 18.2% above its trading range ($1.92). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: CMMB is 18.2% above its trading range ($1.92). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: CMMB is currently trading at $2.27, which is considered extended relative to its 30-day fair value range of $1.54 to $1.92.
Technical Outlook: Technically, CMMB is showing sideways momentum. The price is approaching resistance at $1.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 33.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.00 (+560.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CMMB is showing sideways momentum. The price is approaching resistance at $1.75. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 33.5% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $15.00 (+560.8%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.54 -
$1.92
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price significantly overextended (+18.2% above its trading range)
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+33.5%)
- BULLISH: Trading 560.8% below Wall St target ($15.00)
- WARNING: Recommendation downgraded due to 18.2% overvaluation
Trading Range Analysis
30-Day Trading Range
$1.54 -
$1.92
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.48
Resistance Level
$1.75
Current Trend
Sideways
Technical data as of
Jun 29, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-75.67
Wall Street Target
$15.00
(+560.8%)
Share & Embed Analysis
Last updated: July 02, 2026 9:39 PM ET
Data refreshes hourly during market hours. Next update: 10:39 PM
Data refreshes hourly during market hours. Next update: 10:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CMMB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$291 | 63 BUY |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
IMVT
Immunovant Inc |
STRONG BUY
14 analysts |
$46 | 61 BUY |
